Michigan HB4789 allows patients with life-threatening or severely debilitating illnesses to access investigational treatments.
Michigan HB4789, known as the "right to try act," permits patients with advanced or life-threatening illnesses to access investigational drugs, biological products, or devices. It requires health care providers to inform patients about approved treatments and the potential risks and benefits of investigational options. Patients must provide written, informed consent and meet specific criteria to qualify.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.